Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003000 · ClinicalTrials.gov registry record

Morphine for the Treatment of Pain in Patients With Breast Cancer

A clinical trial, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
18
Enrollment target

NCT00003000 is a clinical trial that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003000 has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
18 participants
Enrollment target

Study Summary

RATIONALE: Morphine helps to relieve the pain associated with cancer surgery. Giving morphine in different ways may offer more pain relief. PURPOSE: This randomized clinical trial is studying how well morphine injected directly into the underarm area works compared with morphine injected into the back of the shoulder in treating pain in patients who have breast cancer and who are undergoing axillary lymph node dissection.

Interventions

  • DRUG morphine sulfate
  • DRUG fentanyl citrate

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 1992-05
Est. Completion 2001-06

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT00003000

The ClinicalTrials.gov registry entry for NCT00003000 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which morphine sulfate is the first listed.

NCT00003000 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00003000 about?

NCT00003000 is a clinical study titled "Morphine for the Treatment of Pain in Patients With Breast Cancer". RATIONALE: Morphine helps to relieve the pain associated with cancer surgery. Giving morphine in different ways may offer more pain relief. PURPOSE: This randomized clinical trial is studying how well morphine injected directly into the underarm area works compared with morphine injected into the b...

What is the current status of trial NCT00003000?

This trial is currently completed. The enrollment target is 18 participants. The study started on 1992-05. Estimated completion is 2001-06.

What interventions are being tested in trial NCT00003000?

The interventions under investigation include: morphine sulfate (DRUG), fentanyl citrate (DRUG).

Who is sponsoring clinical trial NCT00003000?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.